Disappearance curves for tumor markers after resection of intrathoracic malignancies

International Journal of Biological Markers

Volumn 14, Issue 2, 1999, Pages 99-105

  Yoshimasu, Tatsuya ^a   Maebeya, S ^a   Suzuma, T ^a   Bessho, T ^a   Tanino, H ^a   Arimoto, J ^a   Sakurai, T ^a   Naito, Y ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Biological half life; Elimination kinetics; Lung cancer; Surgery

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; SQUAMOUS CELL CARCINOMA ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CELL KINETICS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; MALE; MALIGNANT NEOPLASTIC DISEASE; PLASMA HALF LIFE; POSTOPERATIVE PERIOD; REGRESSION ANALYSIS; THORAX CANCER; TUMOR CELL;

EID: 0033038633     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089901400207     Document Type: Article

References (19)

1. Rodrigus P, van Landeghem AA. Prostate specific antigen levels during and after external beam radiotherapy for localized carcinoma of the prostate: predictor of therapeutic efficacy. Strahlenther Onkol 1992; 168: 397-401.
2. Yedema CA, Kenemans P, Voorhorst F, et al. CA 125 half-life in ovarian cancer: a multivariate survival analysis. Br J Cancer 1993; 67: 1361-7.
3. Lange PH, Vogelzang NJ, Golman A, Kennedy BJ, Fraley EE. Marker half-life analysis as a prognostic tool in testicular cancer. J Urol 1982; 128: 708-11.
4. Yoshimasu T, Miyoshi S, Maebeya S, et al. Analysis of the early postoperative serum carcinoembryonic antigen time-course as a prognostic tool for bronchogenic carcinoma. Cancer 1997; 79: 1533-40.
5. Semjonow A, Hamm M, Rathert P. Elimination kinetics of prostate-specific antigen serum and urine. Int J Biol Markers 1994; 9: 15-20.
6. Ueda H, Kusano T, Iwasaki A, Inutsuka S. Postoperative change of serum carcinoembryonic antigen in bronchogenic carcinoma. Med Bull Fukuoka Univ 1991; 18: 187-91.
7. See WA, Cohen MB, Hoxie LD. Alpha-fetoprotein half-life as a predictor of residual testicular tumor. Cancer 1993; 71: 2048-54.
8. Takahashi Y, Ueno M, Mai M. Implication of observation of exponential disappearance of biological markers after resection of hepatic cancer [in Japanese]. Geka 1988; 50: 64-6.
9. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki H, eds. Second International Symposium on Information Theory. Budapest: Akademiai Kaido, 1973: 267-81.
10. Wehmann RE, Blithe DL, Flack MR, Nisula BC. Metabolic clearance rate and urinary clearance of purified β-core. J Clin Endocrinol Metab 1989; 69: 510-7.
11. Straalen JP, Bossens MMF, de Reijke TM, Sanders GTB. Biological half-life of prostate-specific antigen after radical prostatectomy. Eur J Clin Chem Clin Biochem 1994; 32: 53-5.
12. Adachi M, Sekine T, Umemoto A, Tsukikawa S, Imai K, Yachi A. Mechanism of clearance of circulating CA19-9 in rats. Tumor Biol 1990; 11: 51-8.
13. Teppo AM, Simell O. Endogenous clearance rate and synthesis of alphafoetoprotein during and after blood exchange transfusion in hyperbilirubinaemic newborns. Acta Paediatr Scand 1980; 69: 491-8.
14. Verhelst E, Van den Broecke E, Van Meerbeeck J, De Backer W, Blockx P, Vermeire P. Calculation of half-life of carcinoembryonic antigen after lung tumor resection: a case report. Eur Respir J 1991; 4: 374-6.
15. Pecchio F, Rapellino M, Ruffini E, Cavallo A. Half-life of carcinoembryonic antigen following curative resection of adenocarcioma of the lung. Int J Biol Markers 1992; 7: 119-20.
16. Upham J, Campbell B. Utility of squamous cell carcinoma antigen as a tumour marker in primary malignancy. Respiratory Medicine 1992; 86: 201-3.
17. Polenakovic M, Sikole A, Dzikova S, et al. Acquired renal cystic disease and tumor markers in chronic hemodialysis patients. Int J Artif Organs 1997; 20: 96-100.
18. Sarwar M, Tomiyoshi K, Inoue T, et al. CYFRA 21-1 as a tumor marker used in measuring the serum fragment of cytokeratin subunit 19 by immunoradiometric assay. Ann Nucl Med 1994; 8: 301-6.
19. Yamanishi H, Hayakawa M, Nakano N, et al. Carcinoembryonic antigen in resected cases with lung cancer: postoperative validation and recurrence [in Japanese]. Jpn J Lung Cancer 1988; 28: 723-9.